Year: 2017
Type: review
Abstract: Alzheimer's disease (AD) is a type of dementia that causes major issues for patients' memory, thinking, and behavior. Despite efforts to advance AD diagnostic and therapeutic tools, AD remains incurable due to its complex and multifactorial nature and lack of effective diagnostics/therapeutics. Nanoparticles (NPs) have demonstrated the potential to overcome the challenges and limitations associated with traditional diagnostics/therapeutics. Nanotechnology is now offering new tools and insights to advance our understanding of AD and eventually may offer new hope to AD patients. Here, we review the key roles of nanotechnologies in the recent literature, in both diagnostic and therapeutic aspects of AD, and discuss how these achievements may improve patient prognosis and quality of life.
Source: Trends in biotechnology
Institutions: Endocrinology and Metabolism Population Sciences Institute, Non-Communicable Diseases Research Center, Bushehr University of Medical Sciences, Tehran University of Medical Sciences, Stanford University, University Medical Center Groningen, University of Groningen, Brigham and Women's Hospital, Harvard University, The University of Texas at San Antonio
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $7,030
OpenAlex ID: W2725108817
